These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16181532)

  • 21. Examination of soluble Fas (sFas) and soluble Fas ligand (sFasL) in patients with burns.
    Yamada Y; Endo S; Nakae H; Makabe H; Sato N; Wakabayashi G; Kitamura M; Inada K; Sato S
    Burns; 2003 Dec; 29(8):799-802. PubMed ID: 14636754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study on effect of Astragalus injection on left ventricular remodeling and left ventricular function in patients with acute myocardial infarction].
    Zhang JG; Gao DS; Wei GH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):346-8. PubMed ID: 12584831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy: comparison between nonobstructive and dilated-phase hypertrophic cardiomyopathy.
    Zen K; Irie H; Doue T; Takamiya M; Yamano T; Sawada T; Azuma A; Matsubara H
    Int Heart J; 2005 Mar; 46(2):231-44. PubMed ID: 15876807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H; Narita K; Endo S
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of serum soluble Fas/soluble Fas ligand and TNF-alpha on response to interferon-alpha therapy in chronic hepatitis C.
    Toyoda M; Kakizaki S; Horiguchi N; Sato K; Takayama H; Takagi H; Nagamine T; Mori M
    Liver; 2000 Jul; 20(4):305-11. PubMed ID: 10959809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes and clinical significance of serum level of syndecan-4 protein in patients with chronic congestive heart failure].
    Ma X; Ouyang P; Zhang Z; Lai W; Xu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):866-9. PubMed ID: 23948417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients.
    Papathanassoglou ED; Moynihan JA; Vermillion DL; McDermott MP; Ackerman MH
    Shock; 2000 Aug; 14(2):107-12. PubMed ID: 10947151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validation of a septic myocardial inhibition model by intraperitoneal injection of endotoxin in rats].
    Zhao L; Chen W; Liu Y; Zhen J; Sheng B; Zang X; Lu F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):994-997. PubMed ID: 31537226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure.
    Kubota T; Miyagishima M; Alvarez RJ; Kormos R; Rosenblum WD; Demetris AJ; Semigran MJ; Dec GW; Holubkov R; McTiernan CF; Mann DL; Feldman AM; McNamara DM
    J Heart Lung Transplant; 2000 Sep; 19(9):819-24. PubMed ID: 11008069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Mar; 35(3):714-21. PubMed ID: 10716475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble antiapoptotic molecules and immune activation in chronic heart failure and unstable angina pectoris.
    Fiorina P; Astorri E; Albertini R; Secchi A; Mello A; Lanfredini M; Craveri A; Olivetti G; Quaini F
    J Clin Immunol; 2000 Mar; 20(2):101-6. PubMed ID: 10821461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of bisoprolol on serum interleukin-6 and tumor necrosis factor-alpha level in patients with congestive heart failure].
    Tang FK; Hua N; Lu H; Xiao J; Tang XZ; Qi Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1177-9. PubMed ID: 19068205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients.
    Lapinski TW; Kowalczuk O; Prokopowicz D; Chyczewski L
    World J Gastroenterol; 2004 Dec; 10(24):3650-3. PubMed ID: 15534924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma.
    Mezei G; Lévay M; Sepler Z; Héninger E; Kozma GT; Cserháti E
    Pediatr Allergy Immunol; 2006 Sep; 17(6):444-9. PubMed ID: 16925690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression.
    Parissis JT; Adamopoulos S; Rigas A; Kostakis G; Karatzas D; Venetsanou K; Kremastinos DT
    Am J Cardiol; 2004 Nov; 94(10):1326-8. PubMed ID: 15541260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Levels of Inflammatory Cytokines and Expression of BCL2 and BAX mRNA in Peripheral Blood Mononuclear Cells and in Patients with Chronic Heart Failure.
    Liu W; Ru L; Su C; Qi S; Qi X
    Med Sci Monit; 2019 Apr; 25():2633-2639. PubMed ID: 30968846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
    Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of soluble form of Fas molecule in patients with congestive heart failure.
    Okuyama M; Yamaguchi S; Nozaki N; Yamaoka M; Shirakabe M; Tomoike H
    Am J Cardiol; 1997 Jun; 79(12):1698-701. PubMed ID: 9202370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.